Inflammatory disorders

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Diseases, Conditions, Syndromes

Combo therapy helps knock out fungal meningitis

(HealthDay)— A drug regimen containing two powerful antifungal medicines—amphotericin B and flucytosine—reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with amphotericin B ...

Medications

New drug for vaginal yeast infections approved by FDA

(HealthDay)—A new and expensive antifungal drug to treat vaginal yeast infections was approved by the U.S. Food and Drug Administration this week, but critics say it is not needed.

Diseases, Conditions, Syndromes

Better tests needed to identify Candida auris susceptibility

Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available antifungal tests perform ...

Diseases, Conditions, Syndromes

Ice pops interfered with hospital patient's lab tests: report

(HealthDay)—Physicians should be aware that frozen ice pops—a common treat in hospitals—can fool tests designed to detect a fungal infection that threatens people with an weakened immune system, researchers report.

Medications

FDA approves cresemba for serious fungal infections

(HealthDay)—Cresemba (isavuconazonium sulfate) has been approved by the U.S. Food and Drug Administration to treat invasive aspergillosis and invasive mucormycosis, the agency said Friday in a news release.

page 2 from 4